-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on Disc Medicine, Raises Price Target to $104

Benzinga·11/18/2026 15:47:54
Listen to the news
Morgan Stanley analyst Sean Laaman maintains Disc Medicine (NASDAQ:IRON) with a Overweight and raises the price target from $92 to $104.